Background: Silent cerebral infarction is brain injury detected incidentally on imaging; it can be associated with cognitive decline and future stroke. This study investigated cerebral embolization, silent cerebral infarction and neurocognitive decline following thoracic endovascular aortic repair (TEVAR). 
Introduction
Thoracic endovascular aortic repair (TEVAR) has improved survival outcomes in patients with thoracic aortic disease compared with open surgery, with reported elective 30-day mortality rates of 3-8 per cent 1 -4 . Neurological complications of stroke and paraplegia remain a significant risk, however. Stroke occurs in up to 7 per cent of patients following TEVAR, and is associated with a significant increase in postoperative morbidity and mortality 1,4 -6 . Strokes are mainly embolic 4, 5 , as endovascular repair involves the advancement of stiff wires, catheters and delivery devices (up to size 26 Fr) through the aorta, which is often diseased with significant atheroma. Risk factors for stroke include previous stroke, a more proximal extent of repair, high-grade aortic arch atheroma, intraoperative hypotension, chronic renal insufficiency and coverage of the left subclavian artery (LSCA) without revascularization 4 -8 . To date, only two studies 9, 10 have investigated cerebral embolization during TEVAR using transcranial Doppler imaging (TCD).
Perioperative embolization may also cause silent cerebral infarction. This is evidence of cerebral infarction on imaging without acute neurological dysfunction attributable to the lesion 11 , and is commonly investigated using MRI. Studies 12, 13 have shown that silent cerebral infarction is associated with an increased risk of future stroke, dementia, depression, cognitive impairment and early death independent of other vascular risk factors. It is well recognized following other catheter-based procedures (cerebral 14, 15 and coronary 16 angiography, carotid stenting 17 and transcatheter aortic valve implantation 18 ), and a recent study 19 of 19 patients reported an incidence of 63 per cent following TEVAR.
This study was performed to establish the incidence of TCD-detected cerebral embolization, silent cerebral infarction and neurocognitive decline following TEVAR, and to evaluate patient and procedural risk factors for cerebral embolization and silent infarction.
Methods
Ethical approval was obtained from the UK National Research Ethics Service Committee London -Fulham (08/H0711/59), and all patients gave written informed consent. Patients undergoing TEVAR as elective or emergency procedure for any thoracic aortic pathology at two tertiary referral vascular surgery centres (St Mary's Hospital, Imperial College Healthcare NHS Trust, and St Thomas' Hospital, Guy's and St Thomas' NHS Foundation Trust) between January 2012 and April 2015 were eligible for inclusion.
Preoperative evaluation of aortic atheroma
All patients underwent CT angiography (CTA) before surgery in accordance with a standard clinical protocol, with 1-mm slice thickness and intravenous iodinated contrast. Multiplanar three-dimensional image reconstruction was performed on dedicated CT workstations (Extended Brilliance Workspace V3.5.0.2254; Philips Medical Systems, Best, The Netherlands). Two independent interventional radiologists conducted evaluation of the arch and descending thoracic aorta for the presence of aortic atheroma, calcification and mural thrombus. Atheroma was graded quantitatively based on thickness 7, 20 : grade 1, normal; grade 2, intimal thickening; grade 3, atheroma of 5 mm or less; grade 4, atheroma greater than 5 mm; grade 5, mobile lesion. Aortic arch type, based on the relationship of the origins of the supra-aortic vessels to the parallel plane perpendicular to the outer curvature of the arch (I, II, III or bovine) 8 and proximal landing zone according to Ishimaru's classification (zone 0-4) 21 , was also assessed. All elective patients underwent carotid and vertebral artery duplex imaging by qualified vascular sonographers. The circle of Willis was not assessed on CTA.
Cerebral MRI
Cerebral MRI was performed using the Discovery™ MR750w system (GE Healthcare, Little Chalfont, UK) with 3⋅0-T magnet strength, axial diffusion weighted imaging (DWI) and axial T2-weighted fluid-attenuated inversion recovery (FLAIR) with 5-mm slice thickness. MRI was performed before surgery to identify any pre-existing infarcts, and repeated within 72 h after surgery or as soon as the clinical condition of the patient allowed. The sensitivity and specificity of DWI in the detection of acute cerebral ischaemia are 99 and 92 per cent respectively 22 . A bright DWI signal indicates an early or subacute, but not chronic (more than 14 days old), ischaemic lesion. Two independent neuroradiologists blinded to clinical outcomes compared preoperative and postoperative MRI scans, reporting the number, laterality and vascular territory (anterior or posterior circulation, or border zone territory) of new lesions. The surface area of the lesion was measured on the slice containing the greatest diameter of the lesion.
Neurocognitive testing
Neurocognitive testing was performed by a trained assessor before surgery (1 day before TEVAR), after surgery (when medically fit for discharge) and at first follow-up outpatient appointment, approximately 6-8 weeks after discharge. The test battery included the following four tests, which are the recommended core neuropsychological battery for assessment of neurobehavioural outcomes after cardiac surgery 23 24 ), a measure of executive cognitive dysfunction, was also included.
TEVAR intervention group
All procedures were performed under general anaesthesia at both centres, with intravenous heparin maintaining an activated clotting time of 250-350 s. Where satisfactory proximal sealing required coverage of the LSCA, the LSCA was maintained by left carotid-subclavian bypass or a proximal scalloped endograft, custom-made in anatomically suitable cases. Extra-anatomical bypass with visceral debranching (visceral hybrid) or TEVAR with left carotid-subclavian bypass was performed as a single-stage procedure, whereas full arch debranching (left carotid-subclavian bypass and carotid-carotid bypass -arch hybrid) was staged. A spinal drainage catheter was inserted before operation in all patients undergoing visceral hybrid or coverage of more than 25 cm or more than 50 per cent of aortic length. Access was via percutaneous common femoral artery (CFA) puncture or open surgical groin cut-down, and a 22-Fr sheath was inserted. Contralateral percutaneous CFA access was obtained with a 5-Fr sheath for insertion of an imaging catheter. Pharmacological BP manipulation using a glyceryl trinitrate infusion was employed to achieve controlled systemic hypotension with a systolic BP of 80 mmHg for a short period of time only, to aid precise deployment. All procedures were performed in a dedicated vascular hybrid suite by a team that included both an experienced vascular surgeon and an interventional radiology consultant.
Control group
Patients undergoing endovascular aortic repair (EVAR) or fenestrated endovascular aortic repair (FEVAR) of an infrarenal or juxtarenal abdominal aortic aneurysm (AAA) were recruited as a contemporaneous control group. All procedures were performed under general anaesthesia, with intravenous heparin maintaining an activated clotting time of 250-350 s. Access was via bilateral open surgical femoral cut-down. In all control patients, wires and catheters were placed in the proximal descending thoracic aorta and did not cross the aortic arch.
Intraoperative transcranial Doppler assessment
Cerebral embolization detection was performed using bilateral TCD insonation of the middle cerebral artery (MCA). The TCD parameters included a DWL ® Doppler device (Compumedics, Singen, Germany) with two-channel emboli detection software and 2-MHz transducer probes, sample volume 8 mm, median softgain 25 (range , filter setting 150 Hz, and intensity detection threshold above 9 dB. The TCD signal was recorded continuously during procedures, and manual offline analysis was performed by a trained observer for identification of high-intensity transient signals (HITS) characteristic of an embolus. Accepted criteria 25, 26 for embolus detection were used: alteration of Doppler signal to a high intensity (more than 3 dB higher than background blood flow signal), short duration (less than 300 ms) and unidirectional signals in the direction of flow accompanied by a characteristic clicking sound (Fig. 1) .
Differentiation between gas and solid emboli was not undertaken. A period of preoperative monitoring was performed after induction of general anaesthesia and before commencement of TEVAR to detect any spontaneous embolization. TCD was performed during carotid-subclavian bypass but not during full arch debranching for arch hybrids.
Statistical analysis
Statistical analysis was performed using SPSS ® version 22 software (IBM, Armonk, New York, USA). Continuous variables are presented as median (i.q.r. and/or range) and categorical variables as frequency with percentage. Comparisons were made using Mann-Whitney U, Kruskal-Wallis, Wilcoxon signed rank and Friedman's tests, with P < 0⋅050 considered statistically significant. Logarithmic transformation of non-normally distributed variables was used where required. Univariable and multivariable analysis was performed, with P < 0⋅050 as the entry criterion into multivariable analysis. Univariable analysis for continuous variables was done as a linear regression analysis, and that for binary variables as logistic regression.
Results
Fifty-two patients undergoing TEVAR and 24 control patients were recruited ( Table 1) .
Clinical outcomes
All stent-grafts were deployed satisfactorily, with no retrograde type A dissection or open surgical conversion.
No endoleak was identified on completion angiography. Median hospital stay was 8⋅5 (i.q.r. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] days, and median duration of follow-up was 16 (6-27) months. Values in parentheses are percentages unless indicated otherwise; *values are median (i.q.r.). (T)EVAR, (thoracic) endovascular aortic repair; IMH, intramural haematoma; n.a., not applicable; IHD, ischaemic heart disease; LSCA, left subclavian artery. Values in parentheses are percentages. *After failure of percutaneous closure device; †resolved spontaneously; ‡resolved with physiotherapy.
Morbidity and mortality outcomes are detailed in Table 2 . Four patients (8 per cent; all men, two elderly) developed clinical stroke, all detected immediately after surgery (Table S1 , supporting information). Procedures performed included one arch hybrid, two TEVAR with carotid-LSCA bypass, and one proximal stent extension for a type Ia endoleak following previous visceral hybrid repair of type II thoracoabdominal aortic aneurysm. Two patients made a complete recovery following a period of rehabilitation. No patient with stroke died in hospital or within 30 days of surgery.
Intraoperative transcranial Doppler-detected cerebral embolization
TCD monitoring was performed in 42 patients; 30 patients had bilateral insonation, six had left insonation only and six had right insonation only, owing to an inadequate bilateral acoustical temporal bone window. The MCA was insonated in all patients (median depth 50 (range 46-58) mm), except for four patients in whom no MCA signal was identified on the right and therefore the posterior cerebral artery was insonated instead. Cerebral embolization was detected during TEVAR in all 42 patients.
A 53-year-old man undergoing emergency TEVAR and left carotid-subclavian bypass for acute type B dissection was the only patient in whom spontaneous embolization was detected during preoperative monitoring: two emboli were detected at the left MCA.
The median procedural embolization rate for all patients was 179 (i.q.r. 71-262) HITS, 104 excluding contrast injection-related embolization. Embolization resulting from contrast injection was included in all analyses. Stent-graft manipulation and deployment (median 62, i.q.r. 22-163) followed by contrast injection (median 61, 18-117) resulted in the highest rates of embolization (P = 0⋅001) (Fig. 2) .
Embolization varied depending on patient and procedural factors (Fig. 3) , and was detected more frequently at the left MCA (P = 0⋅018), with higher aortic atheroma grades 4 and 5 (P = 0⋅042), at more proximal landing zones 0 and 1 (median 450 versus 72 for zones 3-4; P = 0⋅001), and during arch hybrid procedures (P = 0⋅001). No significant difference in embolization was seen between the treated pathologies.
Ten patients in the control group had TCD assessment. TCD HITS were detected in five of eight patients undergoing EVAR (median 1, i.q.r. 0-1⋅5, range 0-2), and in two patients during FEVAR (6 and 16 HITS).
Cerebral diffusion-weighted MRI
Thirty-one of the 52 patients underwent preoperative and postoperative cerebral MRI (Table S1 , supporting information). Not all patients completed the preoperative and postoperative MRI protocol, for reasons including emergency presentation with unstable patient (6), significant postoperative morbidity or death (5), patients declining MRI due to claustrophobia (7) and contraindication owing to pacemaker (3). Postoperative scans were performed a median of 4 (i.q.r. 2-6) days after TEVAR. Twenty-five of the 31 patients (81 per cent) had evidence of brain injury: 21 (68 per cent) had a procedure-related silent infarction (Fig. 4) and four (13 per cent) had a clinical stroke. All strokes were confirmed as embolic on MRI or CT. There was a trend towards higher rates of embolization in patients with silent infarcts than in those with no postoperative lesions, with the highest rates of embolization in patients with clinical stroke (Fig. 3b) .
In the 21 patients with a silent infarction, a total of 120 new lesions were detected (median 2 (i.q.r. 1-9) per patient), with a total silent infarct surface area of 5459 (median 16, i.q.r. 9-81⋅5) mm 2 . The majority of the lesions were left-sided and in the posterior or border zone circulation.
In the control group, seven patients (6 EVAR, 1 FEVAR) underwent preoperative and postoperative MRI. No patient had a new silent infarction or stroke. 
Risk factors for cerebral embolization and brain injury
Risk factors identified as predictors of TCD-detected cerebral embolization are detailed in Table 3 . The development of brain injury, both silent and stroke (P = 0⋅510), and MRI lesion surface area (P = 0⋅917) were not shown to be associated with embolization. No factors were independent predictors of embolization in multivariable analysis. Similar results were seen with TCD HITS excluding contrast embolization, with the same factors associated with higher embolization rates. In univariable analysis, smoking (odds ratio 8⋅00, 95 per cent c.i. 1⋅13 to 56⋅80; P = 0⋅038) was the only factor significantly associated with the development of brain injury (both silent and stroke), as determined by new MRI lesions.
Neurocognitive outcomes
Neurocognitive testing was performed in 17 patients (Fig. 5) . Postoperative assessment testing was conducted a median of 8 (i.q.r. 5-13) days after TEVAR. Thirty-five patients did not complete neurocognitive testing, owing to a change in the test battery mid-way through the study (24 patients), emergency presentation with an unstable patient (6) and significant postoperative morbidity or death (5) . In 15 patients with a silent cerebral infarction, significant postoperative neurocognitive decline was seen in six of seven domains assessed (all except Trail Making Test B). Univariable analysis revealed age to be a significant predictor of decline in all seven domains, male sex in five domains, and TCD HITS (P = 0⋅009) with memory and recall ( Table  S2 , supporting information).
To assess the effect of silent cerebral infarction on neurocognition, the 17 patients were divided into three groups: two patients who did not develop silent infarcts, eight patients aged less than 70 years with silent infarcts, and seven patients aged 70 years or more with silent infarcts. The median age of patients undergoing neurocognitive testing was 69 years, and this was chosen as the cut-off value between the two age groups. Patients in the older age group showed significant postoperative decline in all areas of neurocognition except Trail Making Test B. This deficit persisted at the follow-up outpatient appointment for the COWAT (P = 0⋅050) and Trail Making Test A (P = 0⋅028), 5 Neurocognitive outcomes. a Results of Controlled Oral Word Association Test (executive cognitive dysfunction). P = 0⋅779 (silent cerebral infarction (SCI) in patients aged less than 70 years); P = 0⋅009 (SCI in patients aged 70 years or more; P = 0⋅027, preoperative versus postoperative; P = 0⋅050, preoperative versus outpatient appointment (OPA)) (Friedman's test). b Results of Trail Making Test A (visual search and motor skills). P = 0⋅050 (SCI in patients aged less than 70 years); P = 0⋅115 (SCI in patients aged 70 years or more; P = 0⋅116, preoperative versus postoperative; P = 0⋅028, preoperative versus OPA) (Friedman's test). c Results of Grooved Pegboard Test with dominant (right) hand. P = 0⋅018 (SCI in patients aged less than 70 years; P = 0⋅046, preoperative versus postoperative; P = 0⋅028, preoperative versus OPA); P = 0⋅011 (SCI in patients aged 70 years or more; P = 0⋅028, preoperative versus postoperative; P = 0⋅310, preoperative versus OPA) (Friedman's test) . Median values and interquartile ranges are denoted by horizontal bars and boxes respectively with median follow-up results remaining below median preoperative levels for both components of the RAVLT ™ . Patients in the younger age group showed a measurable and significant decline affecting both the dominant (P = 0⋅018) and non-dominant (P = 0⋅039) hand in the manual dexterity pegboard test, with persistent decline at follow-up affecting the dominant hand (P = 0⋅028) (Fig. 5) .
Seven patients in the control group (5 EVAR, 2 FEVAR) underwent neurocognitive testing at the three time points. Neurocognitive decline was seen in only one of seven domains tested: COWAT (P = 0⋅002). The decline was seen between preoperative and postoperative testing (P = 0⋅018) and between preoperative and outpatient appointment testing (P = 0⋅027).
Discussion
These results demonstrate TCD-detected cerebral embolization in all patients during TEVAR, with an overall brain injury (both silent and stroke) rate of 81 per cent (25 of 31) in patients who had MRI. The overall stroke rate was 8 per cent, as this cohort includes high-risk patients requiring more proximal landing zones, with several undergoing arch hybrids and LSCA revascularization. The silent infarction rate of 68 per cent (21 of 31) is comparable to the rate of 63 per cent detected by Kahlert and colleagues 19 .
Greater aortic atheroma burden, LSCA bypass, more proximal landing zones (0 and 1), and arch hybrid repairs were shown to be predictors of increased embolization. This is likely due to the more proximal landing zone, which is a documented risk factor for stroke following TEVAR, increased instrumentation of arch vessels, and higher atheroma load and mobile lesions contributing to increased embolization. There were minimal HITS and no silent infarcts in patients undergoing EVAR and FEVAR, probably owing to the proximal landing zone in the abdominal aorta and limited instrumentation in the aortic arch in the control patients. There was a trend towards a higher number of TCD HITS in patients who developed stroke, followed by patients with silent infarcts, with the lowest HITS in those with no postoperative lesions. There was no association, however, between number of TCD HITS and silent cerebral infarction. This is contrary to the findings of Bismuth and co-workers 9 , who showed a significant association between total HITS and postoperative stroke. In their study of 20 patients undergoing TCD during TEVAR, the highest number of HITS was generated by catheter manipulation during the diagnostic phase and by device deployment during the treatment phase. HITS during contrast injection were not examined. This differs from the present findings, where contrast injection contributed the highest HITS during the diagnostic phase, and stent-graft deployment the highest HITS during the treatment phase.
In a study 27 investigating cerebral embolization during cerebral angiography, 150 patients were randomized into three groups: control group with conventional angiography, heparin group with systemic heparinization throughout the procedure, and an air filter group with an air filter between the catheter and contrast syringe. There was an equal number of MRI lesions in the heparin and air filter groups, which was significantly lower than in the control group (P = 0⋅002). TCD HITS were significantly lower in the air filter group (P < 0⋅01) compared with heparin and control groups, which did not differ from each other. This demonstrated the role of air embolization related to contrast injection and catheter flushing in the development of silent cerebral infarcts, and highlighted the importance of reducing both gaseous and solid embolization. The present results are in keeping with this, and showed a high number of TCD HITS generated during both contrast injection and flushing. In addition, analysis of risk factors for embolization revealed comparable results, both including and excluding contrast injection, and results should therefore include and be interpreted with embolization during contrast injection.
Routine clinical examination assesses for focal neurological abnormalities including paresis, ataxia, visual defects and aphasia. Global brain dysfunction such as cognitive decline, memory and mood disturbances, reduction of psychomotor speed and personality changes may be missed because they require specific neurocognitive tests for diagnosis 15, 28 . In 2229 Framingham Offspring Study participants 12 , silent cerebral infarcts predicted an increased risk of stroke and dementia independent of vascular risk factors, and also indicated an increased risk of mild cognitive impairment and death. People with silent infarcts have more than double the risk of dementia, in particular Alzheimer's disease, compared with the general population 29 . Postoperative cognitive dysfunction (POCD) after general anaesthesia and surgery is a recognized phenomenon with multifactorial aetiology 30 .
In patients undergoing open cardiac surgery, cognitive decline was seen in all patients with postoperative diffusion-weighted MRI ischaemic lesions, and in 35 per cent without imaging-identified lesions (P < 0⋅001) 31 . There was also an association between the number of abnormal cognitive test results and ischaemic burden (P < 0⋅001) 31 . This demonstrates that cognitive impairment is associated with perioperative ischaemia and degree of ischaemic load, and not simply a consequence of POCD.
One transcatheter aortic valve implantation (TAVI) study 32 showed that age was independently associated with longitudinal cognitive decline. The neurocognitive control group consisted of an elderly cohort with a decline in only one of seven areas, whereas the similarly elderly TEVAR group had a decline in six of the seven domains. This highlights that, although elderly patients may be affected by general anaesthesia-related POCD, the significant decline seen in multiple domains following TEVAR is most likely a consequence of cerebral ischaemic burden.
Few studies have investigated neurocognitive decline following endovascular procedures to date. Two studies 33, 34 investigating silent cerebral infarction after coronary catheterization found a significant decline in learning and attention, and verbal and non-verbal memory associated with silent infarcts. In the present study, follow-up assessment was performed 6-8 weeks after operation, with no longer-term testing undertaken. A later cognitive assessment may be clinically relevant, but cognitive dysfunction in the postoperative period may predict further decline over the next 5 years 31, 35 .
Significant postoperative decline affecting older patients was observed in six of seven domains assessed, whereas persistent decline at follow-up was demonstrated in three domains. Of concern, even younger patients had significant postoperative decline in manual dexterity, with persistent decline in the use of their dominant hand at follow-up.
Silent cerebral infarction and cognitive decline has implications for patients and should inform the clinical decision-making and consent process for TEVAR. Cerebral embolization needs to be evaluated further, with differentiation between gaseous and solid emboli, and the efficacy of pharmacological and interventional strategies to reduce neurological injury in TEVAR and other endovascular procedures should be determined. Recent RCTs such as CLEAN-TAVI 36 and MISTRAL-C 37 , which used the Sentinel ™ Cerebral Protection System (Claret Medical, Santa Rosa, California, USA) in TAVI, have shown a significant decrease in number and volume of new silent infarcts, with improved neurological outcome.
Robotic navigation has been shown to reduce contact with the aortic arch wall during TAVI, and to cause significantly less cerebral embolization compared with manual techniques during TEVAR due to the active manoeuvrability and stability of the robotic system 38, 39 . A dynamic bubble trap designed to reduce gaseous emboli has been shown to reduce TCD HITS, and cognitive function 3 months after surgery was significantly better compared with that in control patients undergoing coronary artery bypass grafting 40 . It has also been demonstrated that thoracic endografts release significant amounts of air during deployment if flushed according to the instructions for use, and carbon dioxide flushing before standard saline flushing significantly reduces the amount of gas released 41 . This may have a potential role in reducing air embolism during TEVAR, particularly in more proximal landing zones 42 . The severity of aortic atheroma can be addressed with preoperative statin administration, which leads to plaque stabilization and atheroma regression, and smoking cessation is beneficial for plaque stabilization 43 .
A limitation of this study is that, owing to pragmatic issues with the conduct of clinical research of this nature, it was not feasible for all patients to undergo all three investigations of TCD, MRI and neurocognitive testing. Follow-up neurocognitive assessment was performed only at the first outpatient appointment, to coincide with routine follow-up and thereby limit the number of clinic visits.
